Go back

Pharma spend on neglected disease research blooms

Image: Center for Disease Control and Prevention, via Wikimedia Commons

Industry investment reached almost US$600m in 2018, highlighting growth in clinical R&D

The pharmaceutical industry is the second-biggest investor globally in neglected tropical disease R&D, beating the Bill & Melinda Gates Foundation for the second year running, fresh data reveals.

This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com